Summary
We have studied the antiaggregatory effect of fenflumizole, a new non-steroidal antiinflammatory imidazole derivative, in ten patients with unstable angina pectoris.
We have measured the aggregation induced by arachidonic acid (AA), ADP, and collagen, and serum or plasma concentrations of β-thromboglobulin (β-TG), platelet factor 4 (PF-4), thromboxane B2 (TXB2), and fenflumizole before, during, and after treatment with fenflumizole in two different regimens either as 10 mg b.i.d. for four days followed by 10 mg daily for six days (Group I,n=5), or as 20 mg b.i.d. for four days followed by 20 mg daily for six days (Group II,n=5).
The threshold concentration of AA-induced platelet aggregation increased in both groups by the first day of treatment, the mean increase being significantly higher in Group II than in Group I. There was close correlation between serum fenflumizole and the threshold concentration of AA-induced platelet aggregation (r=0.95).
A significant fall in TXB2 occurred in both groups. In group I TXB2 concentrations subsequently increased to initial values during treatment, whereas it remained significantly reduced in Group II. There were no significant changes in collagen and ADP aggregation, and β-TG and PF-4 concentrations remained unchanged during and after the administration of fenflumizole.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
De Wood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303: 897–902
Mehta J (1983) Platelets and prostaglandins in coronary artery disease. J Am Med Assoc 249: 2818–2823
Harker LA, Ritchie J (1980) The role of platelets in acute vascular events. Circulation 62: V 13–18
Sobel M, Salzman EW, Davies GC, Handin RI, Sweeney J, Ploetz J, Kurland G (1981) Circulating platelet products in unstable angina pectoris. Circulation 68: 300–306
Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, Spaet TH (1977) The effect of thrombocytopenia on experimental atherosclerotic lesion formation in rabbits. J Clin Invest 60: 1191–1201
Harker LA, Ross R, Slichter SJ, Scott CR (1976) Homocysteine induced atherosclerosis and the role of endothelial cell injury and platelet response and its genesis. J Clin Invest 58: 731–741
Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandins and thromboxane into coronary circulation in patients with ischemic heart disease. N Engl J Med 304: 685–691
Grande P, Wadt J, Corell T (1984) Influence of fenflumizole on platelet aggregation in man. Eur J Clin Pharmacol 27: 169–172
Hirsh PD, Campbell WB, Willerson T, Hillis LD (1981) Prostaglandins and ischemic heart disease. Am J Med 71: 1009–1026
Weiss HJ (1978) Antiplatelet therapy. N Engl J Med 298: 1344–1347, 1403–1406
Corell T, Hasselmann G, Splawinski J, Wojtaszek B (1983) Fenflumizole: Interactions with the arachidonic acid cascade. Acta Pharmacol Toxicol 53: 297–303
Corell T, Hasselmann G (1983) Pharmacodynamics and toxicology of fenflumizole, a new non-steroidal anti-inflammatory imidazole derivative. Acta Pharmacol Toxicol 53: 288–296
Sorkin RD, Tokarsky JM, Huber-Smith MJ, Steiger JM, McCann DS (1982) In vivo platelet aggregation and plasma catecholamines in acute myocardial infarction. Am Heart J 104: 1255–1261
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grauholt, A.M., Grande, P. & Wadt, J. The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris. Eur J Clin Pharmacol 31, 547–551 (1987). https://doi.org/10.1007/BF00606628
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606628